retatrutide

مستقر6 خبر4 مصادرآخر تحديث: 7 sa önce

أحدث الأخبار

Senior doctors warn against unapproved weight loss drug retatrutide after liver damage cases

Senior doctors in Melbourne are warning the public against taking unapproved weight loss medication labelled as retatrutide, after multiple cases of severe liver damage and other illnesses were discovered. The injectable drug, not approved by any global regulator, is being sold on the black market, with one woman hospitalised in acute liver failure after just two doses.

ABC Top Stories

مُلِح

صحة·8 sa önceملخص الذكاء الاصطناعي

Senior doctors warn against unapproved 'retatrutide' weight loss drug after liver damage cases

Senior doctors in Melbourne are warning the public against using an unapproved weight loss drug labeled as retatrutide, after multiple cases of severe liver damage and other serious illnesses were reported. The injectable medication, not approved by any global drug regulator, is being sold on the black market.

ABC Top Stories

Retatrutide: The New Obesity Drug Promising 30% Weight Loss

يتطور

صحة·25.05.2026ملخص الذكاء الاصطناعي

Retatrutide: The New Obesity Drug Promising 30% Weight Loss

Retatrutide, a new obesity drug from Eli Lilly, has shown a 30% weight loss in trials, surpassing previous drugs like Ozempic. It mimics GLP-1 and other hormones, offering benefits beyond weight loss, including anti-inflammatory effects.

El Mundo

Retatrutide: The New Obesity Drug Promising 30% Weight Loss and Broader Health Benefits

يتطور

صحة·24.05.2026ملخص الذكاء الاصطناعي

Retatrutide: The New Obesity Drug Promising 30% Weight Loss and Broader Health Benefits

Retatrutide, a new obesity drug, has shown a 30% weight loss in trials, surpassing previous drugs. Experts highlight its broader benefits beyond weight loss, including reduced inflammation and improved cardiovascular and kidney function, attributing these to its multi-organ receptor action.

El Mundo

Retatrutide Drug Shows Promising Results in Weight Loss Study

يتطور

صحة·22.05.2026ملخص الذكاء الاصطناعي

Retatrutide Drug Shows Promising Results in Weight Loss Study

A new drug called retatrutide has shown significant weight loss results in a study, with participants losing up to 28.3% of their body weight. The drug targets three hormonal pathways simultaneously, leading to greater weight loss than current medications.

RT عربي

Eli Lilly's Retatrutide Achieves Significant Weight Loss in Late-Stage Trial

يتطور

صحة·21.05.2026ملخص الذكاء الاصطناعي

Eli Lilly's Retatrutide Achieves Significant Weight Loss in Late-Stage Trial

Eli Lilly's new obesity drug, retatrutide, showed significant weight loss in a late-stage trial, with the highest dose leading to an average loss of 28.3% over 80 weeks. The drug targets three gut hormones and appears more effective than existing treatments, bringing Lilly closer to regulatory approval.

CNBC US Markets